Clinical Trial Update: Efficacy and Safety of Vildagliptin in Combination With Glimepiride in Patients With Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of combining vildagliptin with glimepiride in patients with Type 2 diabetes, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Galvus (vildagliptin)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED